Richard Bucala, MD, PhD
Professor of Medicine (Rheumatology), of Epidemiology (Microbial Diseases) and of Pathology and Residential College Associate Fellow in Faculty of Arts and Sciences

Departments & Organizations
Biological and Biomedical Sciences (BBS): Molecular Medicine, Pharmacology, and PhysiologyYale Medical Group
Cancer Immunology
Global Health Initiative: Infectious Diseases
School of Public Health: Parasitology Program
Pathology
Internal Medicine: Rheumatology | Diabetes Endocrinology Research Center
Research Interests
Mechanisms by which host immunity converts from a protective response to one producing disease and tissue pathology; Emergence of steroid resistance; Biochemical, biological, and genetic characterization of cytokine MIF; MIF's role in malaria; Role of fibrocytes in different systemic fibroses
Clinical Interests
Autoimmune diseases; Rheumatoid arthritis; Systemic Fibroses; Y-NHH Consultation
Education
- B.S., Yale University, 1979
- M.S., Yale University, 1979
- Ph.D., Rockefeller University, 1985
- M.D., Cornell College, 1986
Selected Publication
- Leng L, Chen L, Fan J, Greven D, Arjona A, Du X, Austin D, Kashgarian M, Yin Z, Huang XR, Lan HY, Lolis E, Nikolic-Paterson D, Bucala R. 2011. A small-molecule MIF antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice. J Immunol. 186, 527-538.
Latest Honor and Recognition
- American Society for Clinical Investigation (1996)
Articles
May/June 2010
Grants and contracts awarded to Yale School of Medicine
FederalSerap Aksoy, NIH, Tsetse Fecundity Reduction for Tryopanosomiasis Control, 5 years, $2,064,820Karen Anderson,...

May/June 2009
Five medical school faculty are elected to a venerable group
The Association of American Physicians (AAP), a nonprofit professional organization founded in 1885, has announced that...
July/August 2006
How immnity is MIFfed by malaria
Half of the 2 million deaths from malaria each year result from severe anemia caused by the duplicitous Plasmodium...

Aug/Sept 2005
Grants and contracts awarded to Yale School of Medicine
FederalGeorge Aghajanian, NIH, Psychotogenic Drug Action on Chemically Defined Neurons, 4 years, $931,200Thomas...


